According to this study, the global Genomic Testing in Cancer market size will reach US$ million by 2029. This report presents a comprehensive overview, market shares, and growth opportunities of Genomic Testing in Cancer market by product type, application, key players and key regions and countries. Segmentation by product type: Breast Cancer Lung Cancer Blood Cancer Liver Cancer Stomach Cancer Others Segmentation by Application: General Hospitals Specialty Clinics This report also splits the market by region: United States China Europe Other regions: Japan South Korea Southeast Asia Rest of world The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: 23andMe Agilent Technologies Bio-Rad Laboratories Centogene Color Genomics Gene By Gene Illumina LabCorp Myriad Genetics Positive Bioscience Quest Diagnostics Thermo Fisher Scientific
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Genomic Testing in Cancer Market Size 2024-2029 2.1.2 Genomic Testing in Cancer Marke